Conditions: Cystoid Macular Edema
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 662
Healthy volunteers: no

Brief summary:
Prospective, randomized, double-masked, placebo-controlled clinical study to define the effective use of a topical non-steroidal anti-inflammatory drug added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema.

Detailed description:

Arms:
arm 1: nepafenac 0.3% ophthalmic solution dosed once daily arm 2: sterile saline drops with a pH approximately of 7.0 and osmolality of 290 mOsm/kg, dosed at once daily

Interventions: intervention 1: Nepafenac 0.3% intervention 2: Saline Solution
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: